Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
92.84 CHF | -0.25% | +3.40% | +9.38% |
05-13 | Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales | DJ |
05-10 | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.38% | 209B | |
+29.98% | 682B | |
+31.76% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.51% | 240B | |
-8.83% | 203B | |
+7.09% | 165B | |
-1.22% | 161B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Transcript : Novartis AG, Q4 2019 Earnings Call, Jan 29, 2020